Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
NCT06148610 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 170
Last updated 2023-11-28
Summary
Bone marrow transplantation is both a great treatment for patients with hematological diseases. It is also one of the only hopes of staying alive by "starting from scratch". It is a trying life experience, at all its stages. To support these patients and increase their success in healing and returning to a "normal life", quality of life is an ally of choice for the success of care.
NewSpringForMe is an innovative tool designed for the benefit of transplant patients, through the deployment of unprecedented interdisciplinary support benefiting from the best digital technologies. This digital solution is aimed at all patients, adults and pediatrics, before, during and after bone marrow transplantation, in a long-term approach. NewSpringForMe results from the multidisciplinary collaboration of medical and paramedical experts in the field of hematology and transplantation, as well as in the field of psychology.
With NewSpringForMe, each transplant patient has a personalized and scalable space accessible via a web platform, constantly offering, according to their needs and at their own pace, a range of recommendations, tools and exercises in psychology, nutrition / dietetics and physical activity, the three pillars of overall well-being. Perfectly integrated into the care pathway and the transplant protocol, from the announcement of the treatment to the long-term follow-up, several years after the intervention, NewSpringForMe complements the medical treatments provided by the medical profession: the communication of the assessments from the platform as well as patient data for caregivers allows adaptation of therapies and optimization of medical care. Thanks to the consideration of individual parameters and their evolution, and thanks to specific algorithms, each tool is adapted to the course of care and to the life of each patient, as well as to their personal health situation throughout their transplant journey.
In order to demonstrate the benefits of using NewSpringForMe, the project plans to evaluate the platform and its impact on the quality of life in patients with hematological diseases. This evaluation will be done by the patients themselves and by the nursing staff. The evaluation will be carried out using a monocentric approach on a pilot cohort. The objective is to demonstrate that integrative health ensuring simultaneous care of body and mind increases the chances of success of the transplant while limiting post-transplant complications.
Conditions
- Hematologic Diseases
- Bone Marrow Transplantation
- Hematopoietic Stem Cell Transplantation
Interventions
- DEVICE
-
NewSpringForMe digital solution
Follow-up of transplanted patients for hematological diseases using the NewSpringForMe device as support of quality of life
Sponsors & Collaborators
-
Saint-Louis Hospital, Paris, France
collaborator OTHER -
Nutricia Nutrition Clinique
collaborator INDUSTRY -
Clinicprosport
collaborator UNKNOWN -
ELLYE
collaborator UNKNOWN -
Association Aïda
collaborator UNKNOWN - collaborator INDUSTRY
- collaborator INDUSTRY
-
Groupe Apicil
collaborator UNKNOWN -
Association Laurette Fugain
collaborator UNKNOWN -
Fondation du LEEM
collaborator UNKNOWN -
Fondation AFNIC
collaborator UNKNOWN -
Pierre Fabre Medicament
collaborator INDUSTRY - collaborator INDUSTRY
-
University Hospital, Clermont-Ferrand
collaborator OTHER -
LAPSCO, Université Clermont-Auvergne
collaborator UNKNOWN -
Fonds de Dotation HTC Project
lead OTHER
Principal Investigators
-
Régis Peffault de Latour, PU-PH · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-27
- Primary Completion
- 2024-09-30
- Completion
- 2024-12-31
Countries
- France
Study Locations
More Related Trials
-
A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06949267 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Improving Sleep in BMT Survivors
NCT03537963 ·Status: COMPLETED ·Phase: NA
-
Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy
NCT07289087 ·Status: NOT_YET_RECRUITING
-
Quality of Life in Patients Who Have Undergone Stem Cell Transplant
NCT00128960 ·Status: COMPLETED
-
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538 ·Status: COMPLETED ·Phase: NA
-
A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients
NCT03654404 ·Status: COMPLETED ·Phase: NA
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk
NCT02757989 ·Status: COMPLETED ·Phase: NA
-
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
NCT01602211 ·Status: COMPLETED ·Phase: PHASE3
-
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
NCT00281801 ·Status: COMPLETED
-
Graft-versus-host Disease Associated Myelosuppression
NCT02829216 ·Status: UNKNOWN
-
Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant
NCT03125070 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
NCT07157670 ·Status: NOT_YET_RECRUITING
-
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
NCT05709912 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
NCT02934477 ·Status: RECRUITING
-
BMT Autologous MSCs for GvHD
NCT02359929 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
NCT02598752 ·Status: COMPLETED
-
Implementation and Testing of an eHealth Integrated Model of Care for Patients Receiving Allogeneic Stem Cell Transplantation: The SMILe Project
NCT04789863 ·Status: COMPLETED ·Phase: NA
-
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
NCT00075816 ·Status: COMPLETED ·Phase: PHASE3
-
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
NCT00281814 ·Status: COMPLETED
-
Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies
NCT00275678 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
NCT00126477 ·Status: COMPLETED
-
Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors
NCT02200133 ·Status: COMPLETED ·Phase: NA
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
NCT06541002 ·Status: RECRUITING ·Phase: NA